Conduit device and system for implanting a conduit device in a tissue wall

Information

  • Patent Grant
  • 11027103
  • Patent Number
    11,027,103
  • Date Filed
    Tuesday, March 13, 2018
    6 years ago
  • Date Issued
    Tuesday, June 8, 2021
    2 years ago
Abstract
Various embodiments of the present invention provide a conduit device including an attaching device configured for defining a helical pathway through a tissue wall and complementary ring in cooperation for securing the device within an aperture defined in the tissue wall. Some embodiments of the present invention further provide a system for implanting a conduit device in a tissue wall. More specifically, some embodiments provide a system including a coring device for defining an aperture in a tissue by removing and retaining a tissue core and securely implanting a conduit device therein so as to provide fluid communication between a first and second surface of the tissue wall via the conduit device.
Description
FIELD OF INVENTION

This invention relates to devices and methods for creating and maintaining a fluid conduit to establish fluid communication between opposing surfaces of a tissue wall.


BACKGROUND OF THE INVENTION

Construction of an alternative conduit between the left ventricle and the aorta (an apicoaortic conduit, or AAC) to create a double-outlet left ventricle (LV) has been successfully employed to treat a variety of complex congenital LV outflow obstruction (fibrous tunnel obstruction, aortic annular hypoplasia, tubular hypoplasia of the ascending aorta, and patients with diffuse septal thickening, severe LV hypertrophy and a small LV cavity) as well as adult-onset aortic stenosis in patients with complicating preoperative conditions (previous failed annular augmentation procedures, previous infection, previous CABG with patent anterior internal mammary artery grafts, and a porcelain ascending aorta).


However, the AAC insertion procedure has been poorly accepted, primarily because of early valve failures using first-generation bioprostheses as well as the success of direct LVOTO repair and aortic valve replacement. In the United States, despite an aging population, the unadjusted mortality for isolated aortic valve operations in 2001 remained under 4%. Further, the AAC insertion operation, with or without cardiopulmonary bypass, has not been as technically straightforward as direct aortic valve replacement. For most surgeons, AAC insertion is not a familiar operation and is of historical interest only.


Nonetheless, several studies have demonstrated that AAC insertion successfully lessens the LV-aortic pressure gradient, preserves or improves ventricular function and maintains normally distributed blood flow through the systemic and coronary circulation. While there have been several techniques described, the most commonly employed method is the lateral thoracotomy approach with placement of the AAC to the descending aorta. Other techniques include a median sternotomy approach with insertion of the distal limb of the AAC to the ascending aorta, to the transverse part of the aortic arch, or to the intra-abdominal supraceliac aorta.


In general, the thoracic aorta and the left ventricle apex are exposed through a left lateral thoracotomy, and a needle is passed through the apex and into the left ventricle. While the connector is still spaced apart from the apex, the sutures that will fix the connector to the apex are threaded through a cuff on the connector and through the apex in a matching pattern. The cuff is set back from the end of the connector by 1-2 centimeters to allow the end of the connector to extend through the heart muscle and into the left ventricle. Once the sutures are in place, a ventricular coring device is used to remove a core of ventricular muscle, and the pre-threaded sutures are then pulled to draw the connector into the opening until the cuff comes to rest: on the apex. The sutures are tied off, and additional sutures may be added. Either before or after this procedure, the opposite end of the connector is attached to a valved conduit which terminates at the aorta.


The current techniques and technology available to perform AAC insertion were originally designed to be performed on-pump; either with an arrested or fibrillating heart. While off-pump cases have been described, they can be technically difficult due to the shortcomings of presently available conduits and systems for installing such conduits. For example, because existing conduits require the use of sutures to reliably secure the connector in place, it is often difficult for surgeons or other clinicians to insert such sutures reliably in active cardiac and/or vascular tissue.


Some devices and methods have been devised to install an AAC conduit, such as those described generally in U.S. patent application Ser. No. 11/251,100, filed on Oct. 14, 2005, and U.S. patent application Ser. No. 10/915,691, filed on Aug. 11, 2004, both of which are hereby incorporated herein in their entirety by reference. However, these AAC conduit devices and installation systems rely on the use of a flexible flange that is inserted through a pre-defined aperture in the ventricular apex. Thus, such methods require the use of a hemostatic device (such as an occlusion balloon and/or “umbrella” device) to prevent blood loss from the aperture during installation of the AAC conduit.


SUMMARY OF THE INVENTION

Various embodiments of the present invention provide an improved system and method for the insertion of a conduit (such as an AAC conduit) that will significantly simplify the in vivo insertion of a graft into the beating cardiac apex or other tissue walls (such as other areas of the heart including the anterior, lateral, posterior walls of the left or right ventricle, the left or right atrium, the aortic wall, ascending, transverse, or descending, or other blood vessel walls), such that vascular conduit insertions (including AAC procedures) may be rendered far more attractive to clinicians. Because vascular conduits and systems of the present invention may be used to create alternate outflow tracts in “off-pump” procedures, the embodiments of the present invention may effectively reduce and/or negate the detrimental effects of both cardio-pulmonary by-pass (CPB) and global cardiac ischemia. Additionally, because some conduit embodiments of the present invention (for AAC procedures, for example) may be inserted into a ventricular or atrial free wall or cardiac apex, the conduction system of the heart may be avoided, along with the native coronary arteries and grafts from previous surgical revascularization. In some embodiments of the present invention, wherein the system is used to implant an AAC, a small size valve (19 to 21 mm for typical adult body surface areas) is usually adequate; as the effective postoperative orifice is the sum of the native and prosthetic aortic valves. Further, the present invention provides vascular conduits that may be compatible with newer generation biologic valves, such that valved conduit failure is far less likely. Various embodiments of the present invention may also provide general conduit devices (and systems for implanting) suitable for establishing fluid communication between opposing surfaces of tissue walls in a variety of applications, including the establishment of a fluid conduit through the tissue wall of a mammalian urinary bladder.


In one exemplary embodiment, a system is provided for implanting a conduit device (such as an AAC component) in a tissue wall having a first surface and an opposing second surface. According to some embodiments, the system comprises an outer tube defining a guide aperture extending axially through the outer tube and an attaching device extending from a distal end of said outer tube. The attaching device is configured for advancing along a helical path at least partially through the tissue wall such that at least a portion of the attaching device becomes disposed substantially between the first surface and the opposing second surface of the tissue wall when the outer tube is rotated relative to the first surface of the tissue wall. The attaching device, in some system embodiments, comprises at least one of a helical static coil and a helical elastic spring having a sharpened distal end adapted for piercing the tissue wall as the outer tube is rotated relative to the first surface of the tissue wall. According to some such embodiments, the attaching device may define a radially-expanding helix as the attaching device extends away from the distal end of the outer tube.


In some embodiments, the system also comprises a ring operably engaged about an outer surface of the outer tube and configured for cooperating with the attaching device such that at least a portion of the tissue wall is secured between the attaching device and the ring so as to operably engage said outer tube with the tissue wall. According to some such embodiments, the system may further comprise a plurality of ridges disposed on the outer surface of the outer tube. In such embodiments, the ring comprises at least one deformable pawl member operably engaged therewith for releasably engaging the plurality of ridges on the outer surface of the outer tube. In some other embodiments, the system may comprise threading on at least a portion of the outside surface of the outer tube and corresponding threading on at least a portion of an inside surface of the ring. The threading may thus be configured to cooperate for axially securing the ring relative to the outer tube. Furthermore, some system embodiments may further comprise a nut operably engaged about an outer surface of the outer tube and proximal to the ring. The nut may comprise threading on at least a portion on an inside surface thereof, wherein the threading may be configured for cooperating with the threading on at least a portion of the outside surface of the outer tube. Furthermore, the nut may be configured for cooperating with the ring to advance the ring towards the distal end of the outer tube.


In some embodiments, various system components, such as the outer tube and the ring, may be configured to conform to and/or establish a substantially fluid-tight seal with at least a portion a surface of the tissue wall. For example, in some embodiments, the system may comprise a sealing member operably engaged with a distal end of the ring. According to such embodiments, the sealing member may be configured for establishing a substantially fluid tight seal between the ring and the first surface of the tissue wall. In some embodiments, the system may be configured to cooperate and/or operably engage a tissue wall comprising a substantially curved tissue wall. According to some such embodiments, the ring may comprise a frusto-conical assembly configured for receiving at least a portion of the substantially curved tissue wall so as to form a substantially fluid-tight seal between the frusto-conical assembly and the tissue wall.


In some embodiments, the system further comprises an inner tube configured for insertion into the guide aperture defined by the outer tube. According to such embodiments, the inner tube defines a conduit aperture extending axially therethrough. Furthermore, in some such embodiments, the outer tube may comprise a first securing device operably engaged with a proximal end of the outer tube and the inner tube may comprise a complementary second securing device operably engaged with a proximal end of said inner tube. Thus, according to such embodiments, the second securing device may be configured for selectively operably engaging the first securing device so as to operably engage the inner tube with the outer tube to install and maintain the conduit.


In some embodiments, the system may also comprise a coring device configured for advancing through the conduit aperture defined by the inner tube and through the tissue wall to define an aperture therein by removing a tissue core. The coring device may be further configured for carrying the inner tube through the aperture such that the inner tube extends at least partially through the aperture so as to establish fluid communication between the first and second surfaces of the tissue wall. The coring device may define a coring bore extending axially therethrough and configured for receiving the tissue core removed by the coring device. In some embodiments, the coring device may further comprise a piercing rod slidably advancable and retractable within the coring bore. The piercing rod may further comprise a retrieval device operably engaged with a distal end thereof and configured for axially retaining the tissue core removed by the coring device. Thus, in some embodiments, the piercing rod may be configured for advancing so as to pierce the tissue wall prior to removal of the tissue core and/or retracting after removal of the tissue core such that the tissue core is retrievable via a proximal end of the coring device. In some such embodiments, the coring device may further comprise a handle operably engaged with the proximal end of the coring device. The handle may define a tissue core chamber in communication with the coring bore, the tissue core chamber configured for receiving the tissue core retrieved by the retraction of the piercing rod. Furthermore, in some such embodiments, at least a portion of the handle may comprise a transparent material such that the tissue core received therein is visible from a position outside the handle.


The various embodiments of the present invention may thus be configured for implanting a conduit device that is adapted for providing a conduit for a medical procedure. Such procedures may include, but are not limited to: bypass; cardiac valve repair or replacement; attachment of a ventricular assist device; establishment of an apicoaortic conduit (AAC) and combinations of such procedures.


Use of this new conduit device, system, and method will significantly improve the ease and safety of conduit insertion (such as the implantation of AAC devices, for example). For example, various embodiments of the present invention may allow the outer tube to be securely operably engaged with the tissue wall (due at least in part to the cooperation of the attaching device and the ring) prior to the removal of a tissue core to define an aperture in the tissue wall. Thus, portions of the system disclosed herein may define a guide aperture extending axially through the outer tube for receiving a coring device that may be configured to be capable of efficiently removing and retrieving a tissue core while substantially simultaneously operably engaging a inner tube in the guide aperture so as to establish fluid communication between first and second opposing surfaces of the tissue wall. As persons of ordinary skill in the art will readily appreciate, the various embodiments of the present invention may also be used in a minimally invasive, endoscopically assisted approach.





BRIEF DESCRIPTION OF THE DRAWINGS

Having thus described various embodiments of the invention in general terms, reference will now be made to the accompanying drawings, which are not necessarily drawn to scale, and wherein:



FIG. 1 shows a non-limiting perspective view of an exemplary system for implanting a conduit device, according to one embodiment of the present invention;



FIG. 2 shows a non-limiting side cross-sectional view of an exemplary system for implanting a conduit device, according to one embodiment of the present invention;



FIG. 3 shows a non-limiting side cross-sectional view of an exemplary conduit device implanted in a tissue wall, according to one embodiment of the present invention;



FIG. 4 shows a non-limiting side view of an exemplary system for implanting a conduit device, according to one embodiment of the present invention;



FIGS. 5A-5G show an exemplary set of views of the installation of a conduit device using an exemplary system, according to one embodiment of the present invention;



FIG. 5A shows a non-limiting side cross-sectional view of an exemplary system for implanting a conduit device comprising an attaching device at least partially implanted in a tissue wall, according to one embodiment of the present invention;



FIG. 5B shows a non-limiting side cross-sectional view of an exemplary system for implanting a conduit device comprising an attaching device and a ring cooperating to secure at least a portion of the tissue wall between the attaching device and the ring so as to operably engage said outer tube with the tissue wall, according to one embodiment of the present invention;



FIG. 5C shows a non-limiting side cross-sectional view of an exemplary system for implanting a conduit device comprising a coring device carrying an inner tube configured for insertion into a guide aperture defined by the outer tube, wherein the coring device is advanced at least partially through the tissue wall so as to remove a tissue core thereof, according to one embodiment of the present invention;



FIG. 5D shows a non-limiting side cross-sectional view of an exemplary system for implanting a conduit device comprising a coring device carrying an inner tube configured for insertion into a guide aperture defined by the outer tube, wherein the coring bore defined by the coring device contains a tissue core removed from the tissue wall, according to one embodiment of the present invention;



FIG. 5E shows a non-limiting side cross-sectional view of an exemplary system for implanting a conduit device comprising a coring device carrying an inner tube configured for insertion into a guide aperture defined by the outer tube, wherein a piercing rod is retracted through the coring bore after removal of the tissue core such that the tissue core is retrievable via a proximal end of the coring device, according to one embodiment of the present invention;



FIG. 5F shows a non-limiting side cross-sectional view of an exemplary system for implanting a conduit device, wherein the outer tube and inner tube are installed in the tissue wall so as to establish fluid communication between the first and second surfaces of the tissue wall, according to one embodiment of the present invention;



FIG. 5G shows a non-limiting side cross-sectional view of an exemplary coring device, wherein a handle operably engaged with a proximal end of the coring device contains a tissue core removed from the tissue wall by the coring device, according to one embodiment of the present invention;



FIG. 6 shows a non-limiting side view of an exemplary coring device carrying an inner tube configured for insertion into a guide aperture defined by the outer tube, according to one embodiment of the present invention; and



FIG. 7 shows a non-limiting perspective view of an exemplary conduit device comprising an attaching device comprising a helical spring, according to one embodiment of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

The present inventions now will be described more fully hereinafter with reference to the accompanying drawings, in which some, but not all embodiments of the inventions are shown. Indeed, these inventions may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements Like numbers refer to like elements throughout. The singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise.


Although some embodiments of the invention described herein are directed to a conduit device 1 (see FIGS. 1 and 7, for example) and a system for implanting such a device to form an apicoaortic connector (AAC) between the cardiac apex and the aorta, it will be appreciated by one skilled in the art that the invention is not so limited. For example, aspects of the conduit device 1 and systems of the present invention can also be used to establish and/or maintain conduits in a variety of tissue structures using minimally-invasive and/or invasive delivery techniques. Furthermore, while the embodiments of the invention described herein are directed to the thoracoscopic implantation of the conduit device to form at least one port for establishing an AAC, it should be understood that the system and/or vascular conduit device embodiments of the present invention may be used to establish valved and/or open conduits (including bypass conduits) to augment native blood vessels in order to treat a variety of vascular conditions including, but not limited to: aortic valvular disease, congestive heart failure, left ventricle outflow tract obstructions (LVOTO), peripheral arterial obstructions, small vessel obstructions, and/or other conditions. Furthermore, the vascular conduit device and system of the present invention may also be used to establish a port for inter¬ventricular repairs such as, for example, valve repair and/or replacement or ablation procedures. Thus, the conduit device 1 described in further detail below may also comprise a threaded fluid-tight cap, and/or a cap having at least one pawl member (for engaging corresponding ridges defined on an outer surface of the conduit device 1) for selectively sealing a proximal end of the conduit device 1 such that the inner tube 40 thereof may serve as a re-usable port for repairing and/or treating diseased portions of the cardiac anatomy. Furthermore, the conduit device 1 and system embodiments of the present invention may also be used to implant a conduit and/or port for left ventricular assist devices.


It should be further understood that various embodiments of the conduit device 1 described herein may also be utilized to establish fluid communication between opposing surfaces of a variety of tissue walls and/or anatomical structures. For example, in some embodiments, the conduit device 1 and system for implanting described herein may be used to establish a conduit (and consequently fluid communication) between opposing surfaces of a wall of an anatomical structure that may include, but is not limited to: a urinary bladder; a gall bladder; a diaphragm; a thoracic cavity; an abdominal cavity; an intestinal structure; a cecal cavity; and other tissue wall structures.


It should be understood that the various conduit device 1 components described herein (see, for example, the components shown in FIG. 1) may comprise a variety of biocompatible materials including, but not limited to: stainless steel; titanium substantially rigid biocompatible polymers; elastomeric biocompatible polymers; and combinations of such materials. For example, in some embodiments, the outer tube 10, ring 30, nut 20, and inner tube 40 may comprise substantially rigid biocompatible polymers. In some embodiments, the attaching device 15 may comprise a biocompatible metal and/or metal alloy that may be embedded substantially within and/or operably engaged with an injection-molded polymer used to form the outer tube 10. Furthermore, as described further herein, some embodiments of the present invention may further comprise a sealing member 35 operably engaged with a distal end of the ring 30. In such embodiments, the sealing member 35 may comprise a substantially compliant biocompatible polymer (such as an elastomeric polymer) that may be suitable for establishing a substantially fluid tight seal between the ring 30 a surface of the tissue wall 850. Similarly, the various components of the coring device 2 described herein may also comprise a combination of biocompatible materials suitable for removing and retaining the tissue core 850a in order to define an aperture in the tissue wall 850 such that the inner tube 40 may be installed to establish fluid communication between the opposing first and second surfaces 855, 853 of the tissue wall 850 (as shown in FIG. 3, for example).



FIG. 3 shows some exemplary components of a system for implanting a conduit device 1 in a tissue wall 850 having a first surface 855 and an opposing second surface 853. As shown generally in FIGS. 1 and 2, such a system may comprise an outer tube 10 defining a guide aperture extending axially therethrough and an attaching device 15 extending from a distal end of the outer tube 10. As shown in FIG. 3, for example, the attaching device 15 may be configured for advancing along a helical path at least partially through the tissue wall 850 such that at least a portion of the attaching device 15 becomes disposed substantially between the first surface 855 and the opposing second surface 853 of the tissue wall 850 when the outer tube 10 is rotated relative to the first surface 855 of the tissue wall 850. As shown generally in FIG. 2, the attaching device 15 may be integrally formed within the outer tube 10. For example, the attaching device 15 may, in some embodiments, be placed at least partially in a mold such that the polymeric or other components of the outer tube 10 may be molded substantially around at least a portion of the attaching device 15 (which may comprise a static coil and/or elastic spring, as described further herein). In other embodiments, the attaching device 15 may be operably engaged with at least a portion of the outer tube 10 via adhesive, RF welding, and/or other attachment methods that may be suitable for securely operably engaging the attaching device 15 to the outer tube 10.


The attaching device 15 may comprise, in some embodiments, a helical static coil having a sharpened distal end adapted for piercing the tissue wall 850 as the outer tube 10 is rotated relative to the first surface 855 of the tissue wall 850. In other embodiments, the attaching device 15 may comprise a helical elastic spring having a sharpened end adapted for piercing the tissue wall 850 as the outer tube 10 is rotated relative to the first surface 855 of the tissue wall 850. In some embodiments, as shown in FIG. 4, wherein the attaching device 15 comprises a helical spring and/or coil, the spring and/or coil may device a radially-expanding helix as the attaching device 15 extends away from the distal end of the outer tube 10. In some embodiments, wherein the attaching device comprises a conical and/or “radially-expanding” helix, the attaching device 15 may act to compress at least a portion of the tissue wall 850 radially inward and towards an outer surface of the inner tube 40 so as to establish a substantially fluid-tight seal between the outer surface of the inner tube 40 and the portion of the tissue wall 850 that has been urged radially inward. Furthermore, in some such embodiments, the radially-expanding helix of the attaching device 15 may correspond, for example, to a ring 30 comprising a frusto-conical assembly configured for receiving at least a portion of a substantially curved tissue wall 850 (see, for example, FIG. 5B) so as to form a substantially fluid-tight seal between the frusto-conical assembly of the ring 30 and the tissue wall 850.


In other embodiments, as shown generally in FIG. 7, the attaching device 15 may comprise a helical spring and/or coil having a substantially constant helical diameter as the attaching device 15 extends away from the distal end of the outer tube 10. The substantially consistent helical diameter of the attaching device 15 shown generally in FIG. 7 may be useful for operably engaging the outer tube 10 with a substantially flat tissue wall 850. Furthermore, as shown generally in FIG. 7, in some embodiments, the corresponding ring 30 (and the corresponding sealing member 35 that may be operably engaged therewith) may also be configured to provide a substantially flat and/or disc-ishaped sealing surface that may be suitable for seating on and/or establishing a substantially fluid-tight seal with a substantially flat first tissue surface 855 that may surround an aperture defined in a correspondingly flat tissue wall 850.


As described herein, the system may further comprise a ring 30 operably engaged about an outer surface of the outer tube 10. As shown generally in FIGS. 3 and 5B, the ring 30 may be configured for cooperating with the attaching device 15 such that at least a portion of the tissue wall 850 is secured between the attaching device 15 and the ring 30 so as to operably engage the outer tube 10 with the tissue wall 850. Some embodiments may further comprise a plurality of ridges 11 and/or threads disposed on the outer surface of the outer tube 10. According to such embodiments, the ring 30 may comprise at least one deformable pawl member configured for releasably engaging the plurality of ridges 11 disposed on the outer surface of the outer tube 10. Other embodiments (as shown generally in FIG. 2, for example), may also further comprise threading 11 on at least a portion of the outside surface of the outer tube 10 and corresponding threading on at least a portion of an inside surface of the ring 30. The threading 11 (and corresponding threading on the inner surface of the ring 30) may be being configured to cooperate for axially securing the ring 30 relative to the outer tube 10. As shown generally in FIGS. 5A-5B, some embodiments may further comprise a nut 20 operably engaged about an outer surface of the outer tube 10 and proximal to the ring 30. According to such embodiments, the nut 20 may comprise threading on at least a portion on an inside surface of the nut 20. The threading disposed on the inside surface of the nut 20 may be configured for cooperating with the threading 11 on at least a portion of the outside surface of the outer tube 11 for axially securing the nut 20 relative to the outer tube 10 and the adjacent ring 20. As shown in FIGS. 5A-5B, the nut 20 may be configured for cooperating with the ring 30 to advance the ring 30 towards the distal end of the outer tube 10. As shown generally in FIGS. 5A-5B, the attaching device 15 may provide counter-traction so as to allow for the rotation (and resulting advancement) of the nut 20 (and the ring 30 disposed distally thereto) such that rotation of the nut 20 (and the corresponding movement of the ring 30 toward the first tissue surface 855) may draw at least a portion of the tissue wall 850 into engagement with an inner surface of the ring 30 such that the conduit device 1 (and particularly the outer tube 10 thereof) is stabilized, engaged in a substantially fluid tight seal, and/or operably engaged with respect to the tissue wall 850 prior to the use of a coring device 2 for removing a tissue core 850a via the guide aperture defined axially through the outer tube 10.


In order to ensure that the ring 30 forms a substantially fluid-tight seal with the first surface 855 of the tissue wall 850 about the aperture defined therein, some embodiments (as shown in FIG. 1, for example) may further comprise a sealing member 35 operably engaged with a distal end of the ring 30. The sealing member 35 may comprise, for example, a gasket or other elastomeric component configured for establishing a substantially fluid tight seal between the ring 30 and the first surface 855 of the tissue wall 855. As described herein, some embodiments of the present invention may be configured for establishing fluid communication between the opposing sides of the walls of a mammalian heart (such as the ventricular apex, for example). In such embodiments, the conduit device 1 may be required to be operably engaged with a substantially curved tissue wall 850 (see FIG. 5A, for example). In such embodiments, the ring 30 may comprise a frusto-conical assembly configured for receiving at least a portion of the substantially curved tissue wall 850 so as to form a substantially fluid-tight seal between the frusto-conical assembly of the ring 30 and the tissue wall 850. As shown, for example, in FIG. 5B, in some embodiments, the ring 30 may be urged towards a distal end of the outer tube 10 by the rotation of a nut 20 about threading 11 disposed on an outer surface of the outer tube 10. Thus, according to some such embodiments, the cooperation of the attaching device 15 (which may comprise a piercing helical spring and/or coil, for example) with the ring 30 may act to draw at least a portion of the curved tissue wall 850 into the frusto-conical assembly of the ring 30 such that a substantially fluid-tight seal may be formed and maintained between the frusto-conical assembly of the ring 30 and the tissue wall 850. In some conduit device 1 embodiments, as shown generally in FIG. 2, the ring 30 may comprise a seal testing aperture 36 that may allow a clinician to selectively test whether or not a substantially fluid-tight seal has been established between the ring 30 and the first surface 855 of the tissue wall 850 when the ring 30 is moved towards the distal end of the outer tube 10 and into engagement with the tissue wall 850. For example, a clinician may operably engage a fluid source (such as a saline solution bag) with the seal testing aperture 36 (which may comprises a luer lock connector or other connector for operably engaging the fluid source) and introducing a fluid via seal testing aperture 36 and observing the interface between the ring 30 and the first surface 855 of the tissue wall 850 to see if any substantial amount of fluid emerges. If no fluid is readily visible, a clinician may be reasonably assured that the seal formed between the ring 30 and the tissue wall 850 is substantially fluid-tight. By assessing the seal formed between the ring 30 and the tissue wall 850, a clinician may determine if it is medically safe to introduce the coring device 2 via the guide conduit defined in the outer tube 10 (i.e. determine if blood loss is likely to occur between the ring 30 and the first surface 855 of the tissue wall 850 when the coring device 2 (and the coring cylinder 65 thereof) is advanced through the tissue wall 850 as shown in FIG. 5C).


In some embodiments, the seal testing aperture 36 may also serve an alternative function for rotationally securing the ring 30 relative to and the first surface 855 of the tissue wall 850. For example, a clinician may insert a needle and/or other elongate spike through the seal testing aperture 36 defined in the ring 30 and substantially into the tissue wall 850. The interaction of the needle and/or spike with the ring 30 (via the seal testing aperture 36) and the tissue wall 850 may thus reduce a chance that the ring 30 (and the helical attaching device 15 extending from the outer tube 10) are rotatable relative to the tissue wall 850 such that the ring 30 and the helical attaching device 15 may be less prone to “backing out” of the tissue wall 850 once the seal is established between the ring 30 and the first surface 855 of the tissue wall 850.


In some additional embodiments, as shown generally in FIG. 7, the ring 30 (and/or the sealing member 35 that may be operably engaged therewith) may define a substantially flat and/or disc-shaped annular sealing surface that may be configured for establishing a substantially fluid-tight seal between the ring 30 and a substantially flat first tissue surface 855 about an aperture defined in the tissue wall 850.


Referring to FIG. 5C, for example, some embodiments may further comprise an inner tube 40 defining a conduit aperture extending axially therethrough. The inner tube 40 may be configured for insertion into the guide aperture defined by the outer tube 10. In some embodiments, as shown in FIG. 6, the inner tube 40 may be carried by a coring device 2 that may be advanced through the guide aperture defined by the outer tube 10 and configured for substantially simultaneously removing a tissue core 850a to define an aperture in the tissue wall 850 and operably engaging the inner tube 40 with the outer tube 10 so as to establish and/or maintain a reliable and engageable pathway for fluid communication between the first and second surfaces 855, 853 of the tissue wall 850. In order to facilitate the secure engagement of the outer tube 10 with the inner tube 40, some conduit device 1 embodiments may comprise a first securing device 13 operably engaged with a proximal end of the outer tube 10 and a complementary second securing device 43 operably engaged with a proximal end of the inner tube 40. According to such embodiments, as shown generally in FIG. 2, the second securing device 43 may be configured for selectively operably engaging the first securing device 13 so as to operably engage the inner tube 40 with the outer tube 10. As shown generally in FIG. 6, the second securing device 43 may comprise one or more deformable pawls configured for selectively operably engaging the first securing device 13 as shown in FIG. 2 (wherein the first securing device 13 comprises one or more ridges disposed on a proximal portion of the outer surface of the outer tube 10).


As shown generally in FIG. 6, some system embodiments for installing a conduit device 1 may further comprise a coring device 2 configured for advancing through the conduit aperture defined by the inner tube 40 and through the tissue wall 850 to define an aperture therein by removing a tissue core 850a (see FIG. 5D, for example, showing the coring device 2 removing a tissue core 850a and collecting the tissue core 850a in a coring bore defined by a coring cylinder 65. As shown generally in FIGS. 5C and 6, the coring device 2 may be further configured for carrying the inner tube 40 through the aperture such that the inner tube 40 extends at least partially through the aperture (see FIG. 5F, for example) so as to establish fluid communication between the first 855 and second 853 surfaces of the tissue wall 850. In some embodiments, as shown in the cross-sectional side view of FIG. 5D, the coring device 2 (and/or the coring cylinder 65 thereof) defines a coring bore extending axially therethrough configured for receiving the tissue core 850a removed by the coring cylinder 65.


As shown in FIGS. 5C-5E, the coring device 2 may also comprise a piercing rod 60 slidably advancable and retractable within the coring bore defined by the coring device 2. The piercing rod 60 may further comprise a retrieval device 61 operably engaged with a distal end thereof and configured for axially retaining the tissue core 850a removed by the coring cylinder 65. In various embodiments, the retrieval device 61 may include, but is not limited to: a barb; a hook; corkscrew; expandable balloon; a self-expanding structure; and/or other device configured for initially piercing the tissue wall 850 so as to be capable of retrieving the tissue core 850a removed by the coring device 2 as described further herein. As shown generally in FIG. 5C, the piercing rod 60 may be configured for advancing so as to pierce the tissue wall 850 prior to removal of the tissue core 850a (i.e. prior to the advancement of the coring cylinder 65 through the tissue wall 850). Furthermore, as shown generally in FIG. 5E, the piercing rod 60 may be further configured for retracting after removal of the tissue core 850a such that the tissue core 850a is retrievable via a proximal end of the coring device 2. In some system embodiments for installing a conduit device 1, the coring device 2 may further comprise a handle 63 operably engaged with a proximal end of the coring device 2 (and/or a proximal end of the coring cylinder 65). According to such embodiments, as shown generally in FIG. 6, the handle 63 may define a tissue core chamber 62 in communication with the coring bore defined by the coring cylinder 65. As shown in FIG. 5E, the tissue core chamber 62 may thus be configured for receiving the tissue core 850a retrieved by retraction of the piercing rod 60 (and the retrieval device 61 operably engaged with a distal end thereof). In order to allow a clinician to positively identify and/or confirm the removal and retraction of the tissue core 850a, in some system embodiments at least a portion of the handle 63 may be provided with a substantially transparent material (such as a transparent polycarbonate polymer, for example) such that the tissue core 850a received by the tissue core chamber 62 may be visible (to a clinician or an endoscopic imaging device, for example) from a position substantially outside the handle 63.



FIGS. 5A-5G illustrate the various steps involved in the utilization of one embodiment of the system of the present invention for installing a conduit device 1 in a tissue wall 850 (such as the ventricular apex). It should be understood that various embodiments of the present invention may be utilized for installing the conduit device 1 for use in medical procedures that may include, but are not limited to: bypass; cardiac valve repair or replacement; attachment of a ventricular assist device; and combinations of such procedures. As shown in FIG. 5A, an exemplary process for installing a conduit device 1 may begin with the implantation of the attaching device 15 in the tissue wall 850. As described herein, the attaching device 15 may comprise a helical spring and/or coil configured for advancing along a helical path at least partially through the tissue wall 850 such that at least a portion of the attaching device 850 becomes disposed substantially between the first surface 855 and the opposing second surface 853 of the tissue wall 850 when the outer tube 10 is rotated relative to the first surface 855 of the tissue wall 850. In some embodiments, the attaching device 15 may be sized such that the axial length of the attaching device 15 does not extend substantially distal to the second surface 853 of the tissue wall 850.


In some embodiments, wherein the attaching device comprises a conical and/or “radially-expanding” helix, the attaching device 15 may act to compress at least a portion of the tissue wall 850 radially inward and towards an outer surface of the inner tube 40 so as to establish a substantially fluid-tight seal between the outer surface of the inner tube 40 and the portion of the tissue wall 850 that has been urged radially inward by the conical and/or radially-expanding helix of the attaching device 15. Furthermore, in embodiments wherein the attaching device 15 comprises a conical and/or “radially-expanding” helix, the attaching device 15 may act to compress at least a portion of the tissue wall 850 radially inward such that the portion of the tissue wall 850 may be more readily received by ring 30 (which may comprise a frusto-conical structure configured for receiving the compressed portion of the tissue wall 850). As shown in FIG. 5B, the conduit device 1 installation process may continue with the advancement and/or tightening of the ring 30 towards a distal end of the outer tube 10. As described herein, some conduit device 1 embodiments of the present invention may comprise a nut 20 operably engaged about an outer surface of the outer tube 10 proximal to the ring 30. In some such embodiments, the nut 20 may comprise threading on at least a portion on an inside surface thereof, wherein the threading is configured for cooperating with the threading 11 on at least a portion of the outside surface of the outer tube 10. The nut 20 may thus be configured to cooperate with the ring 30 to advance the ring 30 towards the distal end of the outer tube 10, and therefore into contact with the first surface 855 of the tissue wall 850. As shown generally in FIG. 5B, once the nut 20 and ring 30 are advanced distally (which may be accomplished by hand-tightening the nut 20), the ring 30 may cooperate with the attaching device 15 such that at least a portion of the tissue wall 850 is secured between the attaching device 15 and the ring 30 so as to securely operably engage the outer tube 10 with the tissue wall 850.


As shown in FIG. 5C, once the outer tube 10 is stabilized relative to the tissue wall 850, a coring device 2 (which, in some embodiments, as shown in FIG. 6, may be configured for carrying an inner tube 40), may be inserted into the guide aperture defined axially within the outer tube 10. As described herein with respect to FIG. 6, the coring device 2 may comprise a coring cylinder 65 configured for advancing through the conduit aperture defined by the inner tube 40 and through the tissue wall 850 to define an aperture therein by removing a tissue core 850a (see FIG. 5D, for example). Referring again to FIG. 5C, some embodiments may further comprise a piercing rod 60 slidably advancable and retractable within the coring bore defined by the coring cylinder 65. The piercing rod 60 may comprise, in some embodiments, an elongate proximal end that may be manipulated (i.e. extended and/or retracted) by a clinician in order to initially pierce the tissue wall 850 and/or retract the tissue core 850a removed therefrom (as described further herein). As shown in FIGS. 5D and 5E, the piercing rod 60 may further comprise a retrieval device 61 operably engaged with a distal end thereof and configured for axially retaining the tissue core 850a removed by the coring cylinder 65. The piercing rod 60 may be configured for advancing so as to pierce the tissue wall 850 prior to removal of the tissue core 850a (i.e. prior to advancement of the coring cylinder 65). Furthermore, as shown in FIG. 5E, the piercing rod 60 may be further configured for retracting after removal of the tissue core 850a such that the tissue core 850a is retrievable via a proximal end of the coring device 2.


As shown in FIGS. 5D and 6, the coring device 2 may be further configured for carrying the inner tube 40 through the aperture such that the inner tube 40 extends at least partially through the aperture so as to establish fluid communication between the first and second surfaces 855, 853 of the tissue wall 850 (see also, FIG. 3, for example). As described herein, with respect to various conduit device 1 embodiments of the present invention the outer tube 10 may comprise a first securing device 13 operably engaged with a proximal end thereof and the inner tube 40 (carried, for example, by the coring device 2 into position relative to the outer tube 10) may comprise a complementary second securing device 43 operably engaged with a proximal end thereof. As shown generally in FIG. 3, the second securing device 43 (which may comprise a deformable pawl, for example) may be configured for selectively operably engaging the first securing device 13 (which may comprise a complementary at least one ridge disposed on an outer surface of the outer tube 10) so as to positively and securely operably engage the inner tube 40 with the outer tube 10.


Referring again to FIG. 5E, the coring device 2 may, in some embodiments, comprise a handle 63 operably engaged with a proximal end of the coring device 2. As described herein, the handle 63 may define a tissue core chamber 62 in communication with the coring bore defined, for example, by the coring cylinder 65. The tissue core chamber 62 may thus be configured for receiving the tissue core 850a retrieved by retraction of the piercing rod 60 (and the retrieval device 61 operably engaged with a distal end thereof). In some embodiments, the coring device 2 may also define a fill aperture configured for operably engaging a source of saline solution or other fluid that may be used to substantially flood the coring bore defined by the coring cylinder 65 and the tissue core chamber 62 so as to reduce the chance of introducing gas bubbles (i.e. air bubbles) into an interior chamber defined by the tissue wall 850 when the coring device 2 is introduced via the outer tube 10.


As described generally herein with regard to the various system embodiments of the present invention, the conduit device 1 installation process may advantageously allow a clinician to visually confirm that the tissue core 850a removed by the coring cylinder 65 has been completely and cleanly removed from the aperture defined in the tissue wall 850. For example, in some embodiments, at least a portion of the handle 63 may comprise a transparent material such that the tissue core 850a received within the tissue core chamber 62 may be directly visible by a clinician and/or an endoscopic imaging device from a position substantially outside the handle 63. As shown in FIGS. 5F and 5G, after the coring device 2 (and the tissue core 850a retained in the handle 63 thereof) is retracted and removed from the inner tube 40, a clamp C may be applied to a proximal end of a graft portion that may be operably engaged with the inner tube 40 of the conduit device 1. In other embodiments, the inner tube 40 may comprise one or more ridges defined on an outer surface of the proximal end thereof that may be configured for receiving a deformable cap or other cover for temporarily and/or semi-permanently closing the aperture defined by the installed conduit device 1. As described herein, the conduit device 1 may be utilized as a portion of a two-part bypass system that may comprise another corresponding conduit device 1 installed in a tissue wall 850 defining a wall of the mammalian aorta, for example. The two corresponding conduit devices 1 may then be operably engaged with one another via a valve device so as to form an apicoaortic connection (AAC) in order to bypass, for example, a faulty valve or other mechanical defect present in a subject's cardiac anatomy.


Many modifications and other embodiments of the inventions set forth herein will come to mind to one skilled in the art to which these inventions pertain having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the inventions are not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.

Claims
  • 1. A coring device comprising: a coring cylinder configured for advancing through a tissue wall to define an aperture in the tissue wall by removing a tissue core from the tissue wall, the coring cylinder defining a coring bore extending along a longitudinal axis of the coring device and configured for receiving the tissue core therein, wherein the tissue wall has a first surface and an opposed second surface;a retrieval device configured for piercing the tissue wall, the retrieval device comprising a corkscrew configured for retaining the tissue core; andan attaching device comprising a conical helix and configured for advancing along a helical path at least partially through the tissue wall such that at least a portion of the attaching device becomes disposed substantially between the first surface and opposed second surface of the tissue wall.
  • 2. The coring device of claim 1, wherein the coring cylinder and the retrieval device are movable relative to one another in a direction of the longitudinal axis of the coring device.
  • 3. The coring device of claim 1, wherein a longitudinal axis of the coring cylinder and a longitudinal axis of the retrieval device are coaxial with one another.
  • 4. The coring device of claim 3, wherein the longitudinal axis of the coring cylinder and the longitudinal axis of the retrieval device are coaxial with the longitudinal axis of the coring device.
  • 5. The coring device of claim 1, wherein the retrieval device is configured for piercing the tissue wall prior to removal of the tissue core from the tissue wall.
  • 6. The coring device of claim 1, further comprising a handle engaged with the coring cylinder.
  • 7. The coring device of claim 6, wherein the retrieval device and the handle are movable relative to one another in a direction of the longitudinal axis of the coring device.
  • 8. The coring device of claim 6, further comprising a piercing rod engaged with the retrieval device, wherein the retrieval device and the piercing rod are movable relative to the coring cylinder and the handle in a direction of the longitudinal axis of the coring device.
  • 9. The coring device of claim 8, wherein the piercing rod extends at least partially through the handle.
  • 10. A method comprising: piercing a tissue wall with a retrieval device of a coring device, the retrieval device comprising a corkscrew, the corkscrew compressing at least a portion of the tissue wall inward;advancing a coring cylinder of the coring device through the tissue wall to define an aperture in the tissue wall by removing a tissue core from the tissue wall, the coring cylinder defining a coring bore extending along a longitudinal axis of the coring device and receiving the tissue core therein; andretaining the tissue core with the corkscrew wherein the corkscrew compresses the tissue against the coring device thereby forming a substantially fluid-tight seal between the tissue and the coring device.
  • 11. The method of claim 10, wherein the tissue wall is pierced with the retrieval device prior to removing the tissue core from the tissue wall.
  • 12. The method of claim 10, further comprising moving the coring cylinder and the retrieval device relative to one another in a direction of the longitudinal axis of the coring device.
  • 13. The method of claim 12, wherein the coring cylinder and the retrieval device are moved relative to one another after piercing the tissue wall with the retrieval device.
  • 14. The method of claim 12, wherein the coring cylinder and the retrieval device are moved relative to one another after advancing the coring cylinder through the tissue wall.
  • 15. The method of claim 10, further comprising advancing an attaching device of a conduit device at least partially through the tissue wall prior to piercing the tissue wall with the retrieval device and prior to removing the tissue core from the tissue wall.
  • 16. The method of claim 15, further comprising advancing the coring cylinder and the retrieval device at least partially through a central aperture of a ring of the conduit device, the ring surrounding at least a portion of the attaching device.
  • 17. The method of claim 16, further comprising advancing an inner tube of the conduit device at least partially through the central aperture and at least partially through the aperture in the tissue wall.
  • 18. A system comprising: a conduit device configured for attaching to a tissue wall, the conduit device comprising: an attaching device configured for advancing at least partially through the tissue wall;a ring surrounding at least a portion of the attaching device, the ring defining a central aperture extending therethrough; anda rigid inner tube configured for advancing at least partially through the central aperture, the inner tube defining a conduit aperture extending therethrough; anda coring device configured for defining an aperture in the tissue wall, the coring device comprising: a coring cylinder configured for advancing through the tissue wall to define the aperture in the tissue wall by removing a tissue core from the tissue wall, the coring cylinder defining a coring bore extending along a longitudinal axis of the coring device and configured for receiving the tissue core therein; anda retrieval device configured for piercing the tissue wall, the retrieval device comprising a corkscrew configured for retaining the tissue core and compressing the tissue against the outer surface of the inner tube.
  • 19. The system of claim 18, wherein the coring cylinder and the retrieval device are configured for advancing at least partially through the central aperture.
  • 20. The system of claim 18, wherein the coring cylinder and the retrieval device are configured for advancing at least partially through the conduit aperture.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of co-pending U.S. patent application Ser. No. 15/058,703, filed on Mar. 2, 2016, which is a continuation of U.S. patent application Ser. No. 14/475,068, now U.S. Pat. No. 9,308,015, which is a continuation of U.S. patent application Ser. No. 13/845,960, filed on Mar. 18, 2013, now U.S. Pat. No. 8,858,489, which is a continuation of U.S. patent application No. Ser. No. 12/901,810, filed on Oct. 11, 2010, now U.S. Pat. No. 8,430,836 issued on Apr. 30, 2013, which is a continuation of U.S. patent application Ser. No. 11/739,151, filed on Apr. 24, 2007, now U.S. Pat. No. 7,846,123 issued on Dec. 7, 2010, which are hereby incorporated by reference in their entireties herein.

US Referenced Citations (293)
Number Name Date Kind
3512519 Hall May 1970 A
3540451 Zeman Nov 1970 A
3856021 McIntosh Dec 1974 A
4204541 Kapitanov May 1980 A
4366819 Kaster Jan 1983 A
4769031 McGough et al. Sep 1988 A
4904264 Scheunemann Feb 1990 A
4955856 Phillips Sep 1990 A
5098369 Heilman et al. Mar 1992 A
5129913 Ruppert Jul 1992 A
5139517 Corral Aug 1992 A
5158563 Cosman Oct 1992 A
5222980 Gealow Jun 1993 A
5256160 Clement Oct 1993 A
5290639 Mallory Mar 1994 A
5291179 Ooe et al. Mar 1994 A
5387193 Miraki Feb 1995 A
5447533 Vachon et al. Sep 1995 A
5456714 Owen Oct 1995 A
5488958 Topel Feb 1996 A
5562729 Purdy et al. Oct 1996 A
5577993 Zhu et al. Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5695504 Gifford et al. Dec 1997 A
5728116 Rosenman Mar 1998 A
5738680 Mueller et al. Apr 1998 A
5755697 Jones et al. May 1998 A
5782844 Yoon et al. Jul 1998 A
5797933 Snow et al. Aug 1998 A
5810836 Hussein et al. Sep 1998 A
5810851 Yoon Sep 1998 A
5814005 Barra et al. Sep 1998 A
5824070 Jarvik Oct 1998 A
5824071 Nelson et al. Oct 1998 A
5827316 Young et al. Oct 1998 A
5833698 Hinchliffe et al. Nov 1998 A
5843088 Barra et al. Dec 1998 A
5865791 Whayne et al. Feb 1999 A
5893369 LeMole Apr 1999 A
5910153 Mayengerger Jun 1999 A
5924424 Stevens et al. Jul 1999 A
5944730 Nobles et al. Aug 1999 A
5976174 Ruiz Nov 1999 A
5984956 Tweden et al. Nov 1999 A
5989278 Mueller Nov 1999 A
6001056 Jassawalla et al. Dec 1999 A
6007576 McClellan Dec 1999 A
6022324 Skinner Feb 2000 A
6022367 Sherts Feb 2000 A
6024755 Addis Feb 2000 A
6039748 Savage et al. Mar 2000 A
6066085 Heilman et al. May 2000 A
6079414 Roth Jun 2000 A
6080173 Williamson et al. Jun 2000 A
6080176 Young Jun 2000 A
6113611 Allen et al. Sep 2000 A
6146325 Lewis et al. Nov 2000 A
6241743 Levin et al. Jun 2001 B1
6254564 Wilk et al. Jul 2001 B1
6267732 Heneveld et al. Jul 2001 B1
6273862 Privitera et al. Aug 2001 B1
6290728 Phelps et al. Sep 2001 B1
6346071 Mussivand Feb 2002 B1
6390976 Spence et al. May 2002 B1
6401720 Stevens et al. Jun 2002 B1
6409739 Nobles et al. Jun 2002 B1
6443957 Addis Sep 2002 B1
6458140 Akin et al. Oct 2002 B2
6506197 Rollero et al. Jan 2003 B1
6537300 Girton Mar 2003 B2
6551319 Lieberman Apr 2003 B2
6551322 Lieberman Apr 2003 B1
6551332 Nguyen et al. Apr 2003 B1
6582400 Hawk Jun 2003 B1
6589277 Fabiani et al. Jul 2003 B1
6607541 Gardiner et al. Aug 2003 B1
6638237 Guiles et al. Oct 2003 B1
6651670 Rapacki et al. Nov 2003 B2
6663633 Pierson, III Dec 2003 B1
6669708 Nissenbaum et al. Dec 2003 B1
6673043 Landesberg Jan 2004 B1
6676678 Gifford et al. Jan 2004 B2
6689147 Koster, Jr. Feb 2004 B1
6695859 Golden et al. Feb 2004 B1
6699256 Logan et al. Mar 2004 B1
6705988 Spence et al. Mar 2004 B2
6726648 Kaplon et al. Apr 2004 B2
6732501 Yu et al. May 2004 B2
6740101 Houser et al. May 2004 B2
6776787 Phung et al. Aug 2004 B2
6802806 McCarthy et al. Oct 2004 B2
6808498 Laroya et al. Oct 2004 B2
6824071 McMichael Nov 2004 B1
6827683 Otawara Dec 2004 B2
6863677 Breznock Mar 2005 B2
6869437 Hausen et al. Mar 2005 B1
6942672 Heilman et al. Sep 2005 B2
6978176 Lattouf Dec 2005 B2
6984241 Lubbers et al. Jan 2006 B2
6994666 Shannon et al. Feb 2006 B2
7018384 Skakoon Mar 2006 B2
7033372 Cahalan Apr 2006 B1
7048681 Tsubouchi et al. May 2006 B2
7056286 Ravenscroft et al. Jun 2006 B2
7077801 Haverich Jul 2006 B2
7083631 Houser et al. Aug 2006 B2
7163525 Franer Jan 2007 B2
7182771 Houser et al. Feb 2007 B1
7214234 Rapacki et al. May 2007 B2
7232421 Gambale et al. Jun 2007 B1
7258694 Choi et al. Aug 2007 B1
7309343 Vargas et al. Dec 2007 B2
7331956 Hovda et al. Feb 2008 B2
7404792 Spence et al. Jul 2008 B2
7510561 Beane et al. Mar 2009 B2
7637919 Ishikawa et al. Dec 2009 B2
7717844 Cohn May 2010 B2
7744527 Cohn Jun 2010 B2
7766811 Haverich Aug 2010 B2
7799041 Beane et al. Sep 2010 B2
7842068 Ginn Nov 2010 B2
7846123 Vassiliades et al. Dec 2010 B2
7846179 Belef et al. Dec 2010 B2
7931581 Cohn Apr 2011 B2
7942805 Shambaugh, Jr. May 2011 B2
7993392 Righini et al. Aug 2011 B2
8226670 Beane et al. Jul 2012 B2
8430836 Vassiliades et al. Apr 2013 B2
8556930 Ellingwood Oct 2013 B2
8579790 Jeffery et al. Nov 2013 B2
8764795 Whitman et al. Jul 2014 B2
8840538 Jeffery et al. Sep 2014 B2
8858489 Vassiliades et al. Oct 2014 B2
20010051809 Houser et al. Dec 2001 A1
20020019623 Altman et al. Feb 2002 A1
20020019643 Gifford et al. Feb 2002 A1
20020032462 Houser et al. Mar 2002 A1
20020038127 Blatter et al. Mar 2002 A1
20020045846 Kaplon et al. Apr 2002 A1
20020055737 Lieberman May 2002 A1
20020055738 Lieberman May 2002 A1
20020055739 Lieberman May 2002 A1
20020055740 Lieberman May 2002 A1
20020055742 Lieberman May 2002 A1
20020058958 Walen May 2002 A1
20020095210 Finnegan et al. Jul 2002 A1
20020099394 Houser et al. Jul 2002 A1
20020116018 Stevens et al. Aug 2002 A1
20020177865 McIntosh Nov 2002 A1
20020183786 Girton Dec 2002 A1
20020193806 Moenning et al. Dec 2002 A1
20030014064 Blatter Jan 2003 A1
20030023255 Miles et al. Jan 2003 A1
20030032979 Mortier et al. Feb 2003 A1
20030040765 Breznock Feb 2003 A1
20030045834 Wing et al. Mar 2003 A1
20030078592 Heilman et al. Apr 2003 A1
20030078597 Blatter Apr 2003 A1
20030130668 Nieman et al. Jul 2003 A1
20030181843 Bibber et al. Sep 2003 A1
20030181913 Lieberman Sep 2003 A1
20040002624 Yu et al. Jan 2004 A1
20040050393 Golden et al. Mar 2004 A1
20040068299 Laske et al. Apr 2004 A1
20040073216 Lieberman Apr 2004 A1
20040077989 Goode et al. Apr 2004 A1
20040092858 Wilson et al. May 2004 A1
20040097973 Loshakove et al. May 2004 A1
20040097993 Whayne May 2004 A1
20040098011 Vargas et al. May 2004 A1
20040133155 Varner et al. Jul 2004 A1
20040138701 Peartree et al. Jul 2004 A1
20040153112 Nissenbaum et al. Aug 2004 A1
20040158308 Hogendijk et al. Aug 2004 A1
20040162608 Haverich Aug 2004 A1
20040167547 Beane et al. Aug 2004 A1
20040167551 Gifford, III et al. Aug 2004 A1
20040171905 Yu et al. Sep 2004 A1
20040186490 Gifford et al. Sep 2004 A1
20040225306 Blatter et al. Nov 2004 A1
20040236170 Kim Nov 2004 A1
20050033107 Tsubouchi Feb 2005 A1
20050043781 Foley Feb 2005 A1
20050075656 Beaupre Apr 2005 A1
20050085883 Ollivier Apr 2005 A1
20050101982 Ravenscroft et al. May 2005 A1
20050101983 Loshakove et al. May 2005 A1
20050131451 Kleshinski et al. Jun 2005 A1
20050137609 Guiraudon Jun 2005 A1
20050149093 Pokorney Jul 2005 A1
20050154411 Breznock et al. Jul 2005 A1
20050171479 Hruska et al. Aug 2005 A1
20050177180 Kaganov Aug 2005 A1
20050187568 Klenk et al. Aug 2005 A1
20050192604 Carson et al. Sep 2005 A1
20050209502 Schmid et al. Sep 2005 A1
20050222582 Wenchell Oct 2005 A1
20050250987 Ewers Nov 2005 A1
20050251187 Beane et al. Nov 2005 A1
20050256368 Klenk et al. Nov 2005 A1
20050267495 Ginn et al. Dec 2005 A1
20060020326 Bolduc et al. Jan 2006 A9
20060036313 Vassiliades et al. Feb 2006 A1
20060074484 Huber Apr 2006 A1
20060089707 Vassiliades et al. Apr 2006 A1
20060099716 Tipler et al. May 2006 A1
20060142634 Anstadt et al. Jun 2006 A1
20060161193 Beane et al. Jul 2006 A1
20060167333 Moore et al. Jul 2006 A1
20060178675 Hamman Aug 2006 A1
20060241659 Tulleken et al. Oct 2006 A1
20060259050 De Winter Nov 2006 A1
20070010834 Sharkawy et al. Jan 2007 A1
20070055357 Pokorney et al. Mar 2007 A1
20070060952 Roby et al. Mar 2007 A1
20070066943 Prasad et al. Mar 2007 A1
20070088375 Beane et al. Apr 2007 A1
20070100363 Dollar et al. May 2007 A1
20070106315 Gregoric et al. May 2007 A1
20070106328 Wardle et al. May 2007 A1
20070112361 Schonholz et al. May 2007 A1
20070142849 Ewers Jun 2007 A1
20070167968 Pandey Jul 2007 A1
20070167969 Pandey Jul 2007 A1
20070173879 Pandey Jul 2007 A1
20070197856 Gellman et al. Aug 2007 A1
20070208214 Hjelle et al. Sep 2007 A1
20070265643 Beane et al. Nov 2007 A1
20080004640 Ellingwood Jan 2008 A1
20080009668 Cohn Jan 2008 A1
20080009887 Cohn Jan 2008 A1
20080009891 Cohn Jan 2008 A1
20080039883 Nohilly Feb 2008 A1
20080058846 Vosough Mar 2008 A1
20080076959 Farnan et al. Mar 2008 A1
20080161826 Guiraudon Jul 2008 A1
20080177301 Svensson Jul 2008 A1
20080255597 Pravong et al. Oct 2008 A1
20090012552 Pandey et al. Jan 2009 A1
20090012557 Osypka Jan 2009 A1
20090082778 Beane et al. Mar 2009 A1
20090112062 Bakos Apr 2009 A1
20090203957 LaRose et al. Aug 2009 A1
20090204206 Parquet et al. Aug 2009 A1
20090240264 Tuval et al. Sep 2009 A1
20100004739 Vesely Jan 2010 A1
20100010500 Beane et al. Jan 2010 A1
20100010616 Drews et al. Jan 2010 A1
20100049225 To et al. Feb 2010 A1
20100087907 Lattouf Apr 2010 A1
20100160847 Braido et al. Jun 2010 A1
20100161040 Braido et al. Jun 2010 A1
20100168778 Braido Jul 2010 A1
20110092766 Almog et al. Apr 2011 A1
20110106116 Ducharme et al. May 2011 A1
20110118766 Reichenbach et al. May 2011 A1
20110118770 Pokorney et al. May 2011 A1
20110118833 Reichenbach et al. May 2011 A1
20110144680 Nguyen et al. Jun 2011 A1
20110160850 Bourque Jun 2011 A1
20110190811 Shanley Aug 2011 A1
20110196190 Farnan et al. Aug 2011 A1
20110224785 Hacohen Sep 2011 A1
20110251450 Pagani et al. Oct 2011 A1
20120059212 LaRose et al. Mar 2012 A1
20120059457 Leinsing et al. Mar 2012 A1
20120089181 Shanley et al. Apr 2012 A1
20120123452 Asfora et al. May 2012 A1
20120123461 Gillies et al. May 2012 A1
20120226096 Callaway et al. Sep 2012 A1
20120253386 Rowe et al. Oct 2012 A1
20120296151 Curtis et al. Nov 2012 A1
20120296358 Nguyen et al. Nov 2012 A1
20130012761 Gregoric et al. Jan 2013 A1
20130110228 Braido May 2013 A1
20130116728 Litvack et al. May 2013 A1
20130150654 Stanfield et al. Jun 2013 A1
20130218169 Vassiliades et al. Aug 2013 A1
20130253641 Lattouf Sep 2013 A1
20140039375 Jimenez et al. Feb 2014 A1
20140067057 Callaway et al. Mar 2014 A1
20140100430 Beane et al. Apr 2014 A1
20140148786 Milo May 2014 A1
20140194833 Andrus Jul 2014 A1
20140214159 Vidlund et al. Jul 2014 A1
20140378772 Sundt, III et al. Dec 2014 A1
20140379074 Spence et al. Dec 2014 A1
20150032153 Quadri et al. Jan 2015 A1
20150038770 Colella Feb 2015 A1
20150112120 Andrus Apr 2015 A1
20150196321 Gregory et al. Jul 2015 A1
20150359952 Andrus et al. Dec 2015 A1
20160095705 Keranen et al. Apr 2016 A1
Foreign Referenced Citations (42)
Number Date Country
2 526 920 Feb 2009 CA
1842354 Oct 2006 CN
1 669 042 Jun 2006 EP
1 691 884 Mar 2011 EP
1 628 702 May 2013 EP
1 706 168 Nov 2013 EP
HI 1-500642 Jan 1999 JP
2002-518082 Jun 2002 JP
2006-514569 May 2006 JP
2006-518624 Aug 2006 JP
2007-510522 Apr 2007 JP
WO 9325148 Dec 1993 WO
WO 9625886 Aug 1996 WO
WO 9713463 Apr 1997 WO
WO 9965409 Dec 1999 WO
WO 0000193 Jan 2000 WO
WO 0015147 Mar 2000 WO
WO 0015149 Mar 2000 WO
WO 0041759 Jul 2000 WO
WO 0074747 Dec 2000 WO
WO 03001980 Jan 2003 WO
WO 2004026147 Apr 2004 WO
WO 2004096059 Nov 2004 WO
WO 2004096337 Nov 2004 WO
WO 2005046783 May 2005 WO
WO 2006019755 Feb 2006 WO
WO 2006020651 Feb 2006 WO
WO 2006093970 Sep 2006 WO
2007047933 Apr 2007 WO
WO 2007038109 Apr 2007 WO
WO 2007047212 Apr 2007 WO
WO 2007117612 Oct 2007 WO
WO 2008131453 Oct 2008 WO
WO 2008153872 Dec 2008 WO
WO 2009100198 Aug 2009 WO
WO 2009117435 Sep 2009 WO
2012025927 Mar 2012 WO
WO 2012040233 Mar 2012 WO
WO-2012106422 Aug 2012 WO
WO 2013064529 May 2013 WO
2013189620 Dec 2013 WO
2015109328 Jul 2015 WO
Non-Patent Literature Citations (14)
Entry
International Search Report and Written Opinion for International Patent Application No. PCT/US2008/061404, dated Aug. 19, 2008.
International Preliminary Report on Patentability for International Patent Application No. PCT/US2008/061404, dated Oct. 27, 2009.
Office Action for European Patent Application No. 08 799 829.0, dated Apr. 19, 2012.
Office Action for European Patent Application No. 08 799 829.0, dated Nov. 2, 2012.
Office Action for Japanese Patent Application No. 2010-606491, dated Nov. 13, 2012.
Office Action for European Patent Application No. 08 799 829.0, dated May 27, 2013.
Office Action for Japanese Patent Application No. 2010-606491, dated Jul. 5, 2013.
Extended European Search Report for European Patent Application No. 13 186 508.1, dated Feb. 6, 2014.
Office Action or European Patent Application No. 13 186 508.1, dated Mar. 17, 2014.
Office Action for Canadian Patent Application No. 2,719,951, dated Apr. 30, 2014.
English Translation of Office Action for Japanese Patent Application No. 2013-175430, dated Jul. 11, 2014.
Notice of Allowance for Canadian Patent Application No. 2,719,951, dated Feb. 5, 2015.
English Translation of Office Action for Japanese Patent Application No. 2013-175430, dated May 19, 2015.
Office Action for Japanese Patent Application No. 2013-175430, dated Jan. 5, 2016.
Related Publications (1)
Number Date Country
20180200492 A1 Jul 2018 US
Continuations (5)
Number Date Country
Parent 15058703 Mar 2016 US
Child 15919975 US
Parent 14475068 Sep 2014 US
Child 15058703 US
Parent 13845960 Mar 2013 US
Child 14475068 US
Parent 12901810 Oct 2010 US
Child 13845960 US
Parent 11739151 Apr 2007 US
Child 12901810 US